MIRC’s Anthony Rullo in Prostate Cancer Canada’s newsletter
![Feature image](https://healthsci.mcmaster.ca/wp-content/uploads/2023/07/rulllonews.jpg)
Dr. Anthony Rullo and his team, in collaboration with Dr. Ryan Wylie are developing new synthetic tumor immunotherapeutic "engager" strategies for use against prostate cancer.
The team’s goal is to maximize the recruitment of endogenous harness T cells selectively against tumor cells using multiple low affinity tumor antigen and immune cell binding interactions. Given its potential high selectivity for cancer cells that express higher copy numbers of a target tumor antigen compared to healthy cells, this therapeutic strategy can achieve a much larger therapeutic window enabling for prolonged duration of anti-tumor response with markedly reduced side effects. Their work is funded by Prostate Cancer Canada as part of the 2019 Discovery Grant program, and we are excited to see where this collaboration leads!
McMaster Immunology Research Centre, Research
Related News
News Listing
![This composite image shows researchers Hong Han and Sheila Singh.](https://healthsci.mcmaster.ca/wp-content/uploads/2024/06/FHS24_CRC_Hong_Sheila_CC01.jpg)
Two Faculty of Health Sciences cancer researchers awarded Canada Research Chairs
Dept. Biochem, Dept. Surgery, Feature, Research
June 27, 2024
![Elena Verdu can be seen in this composite image. Verdu is smiling, wearing a green-coloured shirt and a necklace.](https://healthsci.mcmaster.ca/wp-content/uploads/2024/06/Elena-Verdu.jpg)
Elena Verdu appointed director of Farncombe Family Digestive Health Research Institute
Faculty & Staff, Research
June 27, 2024